Reported 100% of Acute Myeloid Leukemia (AML) patients treated in INB-100 remain in complete remission (CR) at the 2024 ...

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health ... AI-powered brain imaging software with enhanced speed. Commenced full rollout of ...

Discover how Remedy Logic's FDA-cleared RAI program, powered by AI, is revolutionizing spine MRI interpretation for radiologists and patients.

and we are very fortunate that we have several partnerships that are already yielding AI products, data advancing our ability to execute on our mission and our aspirations need to be the best place to ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Artificial Intelligence (AI) holds the potential to bring a commercial and economic rebirth for the United States and its ...

Nevro raised its 2024 adjusted EBITDA loss guidance to $18 million-$16 million from its prior loss guidance of $20 ...

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

The company behind ChatGPT didn’t set out to tackle health care. But despite ongoing concerns about its technology’s tendency ...

Study findings could serve as a foundation for broader neuro-monitoring applications across intensive care units globally.

It’s no secret that AI-powered ... remote care, making it possible to deliver personalized treatments customized to each ...